U.S. flag

An official website of the United States government

GTR Home > Tests > Admera Health PGxOne™ Plus

Overview

Test name

Help

Admera Health PGxOne™ Plus (PGxOne™ Plus)

Purpose of the test

Help

This is a clinical test intended for Help: Drug Response, Therapeutic management

Condition

Help

Loading data ......

Click Indication tab for more information.

How to order

Help

Order URL Help: https://www.admerahealth.com

Specimen source

Buccal swab
Isolated DNA
Mouthwash
Peripheral (whole) blood
Saliva
Specimen requirements: https://www.admerahealth.com

Methodology

Help
Molecular Genetics
TTargeted variant analysis
CNV DetectionNext Generation SequencingQuantitative PCR (qPCR)SNP Detection
  • Illumina MiSeq® System

Summary of what is tested

Loading data ......

Click Methodology tab for more information.

Clinical utility

Help

Guidance for selecting a drug therapy and/or dose

Citations
  • Associated drugs carry pharmacogenomics recommendations put forth by the Food and Drug Administration (FDA).

Clinical validity

Help

Pharmacogenomics testing to assess how a patient may respond to prescribed drugs was performed by massively parallel Next Generation Sequencing (NGS). PGxOne™ Plus was developed, and assessed for accuracy and precision by Admera Health, South Plainfield NJ. The sensitivity and specificity of this test are 100% and 100% respectively. The PGxOne™ Plus test is used for clinical purposes. It should not be regarded as investigational or for research. This laboratory is certified under the Clinical Laboratory Improvement Amendments (CLIA) as qualified to perform high complexity clinical laboratory testing. The DNA testing is not a substitute for clinical monitoring.

Citations

Not provided

Testing strategy

Help

Targeted next-generation sequencing panel 000 Targeted next-generation sequencing panel

Test services

Help
  • Clinical Testing/Confirmation of Mutations Identified Previously
  • Pharmacogenomics
  • Result interpretation

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.